Cancer Drug Safety and Public Health Policy
portes grátis
Cancer Drug Safety and Public Health Policy
A Changing Landscape
Lubaczewski, Courtney; Witherspoon, Bartlett; Bennett, Charles
Springer International Publishing AG
12/2022
167
Dura
Inglês
9783031044014
15 a 20 dias
474
Descrição não disponível.
Fluoroquinolone-Associated Disability and Other Fluoroquinolone Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent Years.- Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse Reactions.- Policing of Drug Safety Information under the False Claims Act.- Translating Research Into Health Policy: The Citizen Petition Experience with the Food and Drug Administration.- Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions.- Was there Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occuring in Copenhagen.- Rituximab-associated Progressive Multifocal Leukoencephalopathy: A fatal adverse drug reaction.- Maximum Accuracy Machine Learning Statistical Analysis - A Novel Approach.- Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work.- Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019):A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).- Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth.- Investigating Novel Genetic Fluoroquinolone Associated Disorders.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Health Policy;Novel Informatics;Pharmacovigilance;Cancer Drug Safety;Cancer Blockbuster Drogs;Pharmaceutical Safety;Identification and Reporting of Advere Drug Reaction;Legal Settlements;Multi-Optimal Discriminant Analysis;Adverse Drug Events and Reports (RADAR);Southern Network on Adverse Reactions (SONAR);Anaphylaxis Among Chronic Kidney Disease Patients;Gadolinium-Associated Nephrogenic Systemic Fibrosis;Thalidomide- and Lenalidomide-associated Venous Thromboembolism;Multifocal Leukoencephalopathy;ANTICIPATE Method;Fluoroquinolones and Neuropsychiatric Toxicity;Tyrosine Kinase Inhibitors and Hepatitis B Reactivation;False Claims Actions;Peginesatide- and Immediate and Fatal Anaphylaxis
Fluoroquinolone-Associated Disability and Other Fluoroquinolone Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent Years.- Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse Reactions.- Policing of Drug Safety Information under the False Claims Act.- Translating Research Into Health Policy: The Citizen Petition Experience with the Food and Drug Administration.- Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions.- Was there Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occuring in Copenhagen.- Rituximab-associated Progressive Multifocal Leukoencephalopathy: A fatal adverse drug reaction.- Maximum Accuracy Machine Learning Statistical Analysis - A Novel Approach.- Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work.- Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019):A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).- Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth.- Investigating Novel Genetic Fluoroquinolone Associated Disorders.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Health Policy;Novel Informatics;Pharmacovigilance;Cancer Drug Safety;Cancer Blockbuster Drogs;Pharmaceutical Safety;Identification and Reporting of Advere Drug Reaction;Legal Settlements;Multi-Optimal Discriminant Analysis;Adverse Drug Events and Reports (RADAR);Southern Network on Adverse Reactions (SONAR);Anaphylaxis Among Chronic Kidney Disease Patients;Gadolinium-Associated Nephrogenic Systemic Fibrosis;Thalidomide- and Lenalidomide-associated Venous Thromboembolism;Multifocal Leukoencephalopathy;ANTICIPATE Method;Fluoroquinolones and Neuropsychiatric Toxicity;Tyrosine Kinase Inhibitors and Hepatitis B Reactivation;False Claims Actions;Peginesatide- and Immediate and Fatal Anaphylaxis
